Nasdaq:US$14.59 (-0.41) | HKEX:HK$23.10 (+0.30) | AIM:£2.41 (-0.04)
Search Result
Previous Article   |   Next Article
Announcements & Press Releases, Oncology / Immunology | 4 Jul 2006

Chi-Med plans to broaden clinical trials of its leading oncology drug candidate

1 items
a060704